RN

Rakesh Nayan

Director Director DIN 07825735
DIN 07825735 First appointment Jun 2017 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jun 2017
Shareholding value Locked Premium profile

About Rakesh Nayan

Rakesh Nayan has 9 years in corporate governance. Formerly with 1 company, such as Rbs Drug Formulation Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07825735
Primary Designation Director
First Appointment 06 Jun 2017
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Rbs Drug Formulation Private Limited U74999BR2017PTC034794
Director 06 Jun 2017 2017 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Rbs Drug Formulation Private Limited
Premium access

Shareholding and investment profile for Rakesh Nayan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakesh Nayan

Rakesh Nayan has 9 years in corporate governance. Formerly with 1 company, such as Rbs Drug Formulation Private Limited. Engaged in General Business. Contributes to corporate operations.

Rakesh Nayan is associated with 0 companies as a director.

Rakesh Nayan has expertise in General Business.

Rakesh Nayan has 9 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available